Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|February 20, 2017
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE studyMaria Rita Migliorino, Antonio Santo, Giampiero Romano, et al.
Clinical Colorectal Cancer|April 2, 2018
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program StudyAlessandro Pastorino, Maria Di Bartolomeo, Evaristo Maiello, et al.
Scientific Reports|April 6, 2017
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysisRiccardo Giampieri, Michela Del Prete, Tiziana Prochilo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.
The New England Journal of Medicine|October 23, 2023
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12CMarwan G Fakih, Lisa Salvatore, Taito Esaki, et al.
Cancers|September 3, 2020
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 PandemicAlberto Zaniboni, Michele Ghidini, Francesco Grossi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2024
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancerTiziana Pressiani, Rita Balsano, Laura Giordano, et al.
Clinical Breast Cancer|December 21, 2020
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO StudyNicla La Verde, Elena Collovà, Livio Blasi, et al.
Clinical Colorectal Cancer|March 9, 2019
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual InhibitionLorenza Rimassa, Silvia Bozzarelli, Filippo Pietrantonio, et al.
British Journal of Cancer|September 20, 2017
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trialRiccardo Giampieri, Marco Puzzoni, Bruno Daniele, et al.
Pageof 25